BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31410797)

  • 1. Characterizing Oligonucleotide Uptake in Cultured Cells: A Case Study Using AS1411 Aptamer.
    Reyes-Reyes EM; Bates PJ
    Methods Mol Biol; 2019; 2036():173-186. PubMed ID: 31410797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.
    Reyes-Reyes EM; Teng Y; Bates PJ
    Cancer Res; 2010 Nov; 70(21):8617-29. PubMed ID: 20861190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.
    Bates PJ; Reyes-Reyes EM; Malik MT; Murphy EM; O'Toole MG; Trent JO
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1414-1428. PubMed ID: 28007579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation.
    Reyes-Reyes EM; Šalipur FR; Shams M; Forsthoefel MK; Bates PJ
    Mol Oncol; 2015 Aug; 9(7):1392-405. PubMed ID: 25911416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
    Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
    Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
    Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
    Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
    Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
    J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma.
    Lopes-Nunes J; Lifante J; Shen Y; Ximendes EC; Jaque D; Iglesias-de la Cruz MC; Cruz C
    Eur J Pharm Biopharm; 2020 Sep; 154():228-235. PubMed ID: 32707287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic applications of AS1411 aptamer, an update review.
    Yazdian-Robati R; Bayat P; Oroojalian F; Zargari M; Ramezani M; Taghdisi SM; Abnous K
    Int J Biol Macromol; 2020 Jul; 155():1420-1431. PubMed ID: 31734366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AS1411 aptamer-targeted gold nanoclusters effect on the enhancement of radiation therapy efficacy in breast tumor-bearing mice.
    Ghahremani F; Kefayat A; Shahbazi-Gahrouei D; Motaghi H; Mehrgardi MA; Haghjooy-Javanmard S
    Nanomedicine (Lond); 2018 Oct; 13(20):2563-2578. PubMed ID: 30334677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AS1411 aptamer modified carbon dots via polyethylenimine-assisted strategy for efficient targeted cancer cell imaging.
    Kong T; Zhou R; Zhang Y; Hao L; Cai X; Zhu B
    Cell Prolif; 2020 Jan; 53(1):e12713. PubMed ID: 31691382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.
    Soundararajan S; Wang L; Sridharan V; Chen W; Courtenay-Luck N; Jones D; Spicer EK; Fernandes DJ
    Mol Pharmacol; 2009 Nov; 76(5):984-91. PubMed ID: 19657047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
    Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
    Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells.
    Esawi E; Alshaer W; Mahmoud IS; Alqudah DA; Azab B; Awidi A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
    Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
    Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery, Effect on Cell Viability, and Plasticity of Modified Aptamer Constructs.
    Gissberg O; Zaghloul EM; Lundin KE; Nguyen CH; Landras-Guetta C; Wengel J; Zain R; Smith CI
    Nucleic Acid Ther; 2016 Jun; 26(3):183-9. PubMed ID: 26859550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AS1411 binds to nucleolin via its parallel structure and disrupts the exos-miRNA-27a-mediated reciprocal activation loop between glioma and astrocytes.
    Sun X; Zhang W; Gou C; Wang X; Wang X; Shao X; Chen X; Chen Z
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167211. PubMed ID: 38701957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells.
    Lee KY; Kang H; Ryu SH; Lee DS; Lee JH; Kim S
    J Biomed Biotechnol; 2010; 2010():168306. PubMed ID: 20204158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.
    Luo Z; Yan Z; Jin K; Pang Q; Jiang T; Lu H; Liu X; Pang Z; Yu L; Jiang X
    J Colloid Interface Sci; 2017 Mar; 490():783-796. PubMed ID: 27988470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.